معرفی
Ashley E Ross is an Associate Professor of Urology and Clinical Director of the Polsky Urological Oncology Center at Northwestern University Feinberg School of Medicine. She specializes in prostate cancer, genomics, immunology, targeted therapies, and clinical trials, with a focus on improving diagnosis and treatment outcomes. Her research emphasizes biomarker identification and clinical trial development, particularly for high-risk prostate cancer patients.
Dr. Ross completed her MD and PhD at Johns Hopkins University School of Medicine, followed by residency and a career as an Associate Professor there prior to joining Northwestern in 2020. She leads active clinical trials evaluating novel therapies like darolutamide and imaging techniques such as rhPSMA-PET-MRI for prostate cancer detection and management.
Awards:
- Best Poster Presentation, American Urology Association (2023)
- Best Research Paper, Chicago Urologic Society (2023)
- Johns Hopkins Clinical Scientist Award
- Prostate Cancer Foundation Young Investigator Award
Advisory Roles:
- Scientific Advisory Board Member, Bayer, Lantheus, Veracyte, and BilliontoOne
Affiliations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Clinical and Translational Sciences Institute (NUCATS).
